- Home
- WLDN vs NEO Comparison
WLDN vs NEO Comparison
Compare WLDN & NEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WLDN
- NEO
- Stock Information
- Founded
- WLDN 1964
- NEO 2001
- Country
- WLDN United States
- NEO United States
- Employees
- WLDN N/A
- NEO N/A
- Industry
- WLDN Military/Government/Technical
- NEO Precision Instruments
- Sector
- WLDN Consumer Discretionary
- NEO Health Care
- Exchange
- WLDN Nasdaq
- NEO Nasdaq
- Market Cap
- WLDN 826.2M
- NEO 709.2M
- IPO Year
- WLDN 2006
- NEO 1999
- Fundamental
- Price
- WLDN $113.01
- NEO $6.21
- Analyst Decision
- WLDN Strong Buy
- NEO Buy
- Analyst Count
- WLDN 3
- NEO 8
- Target Price
- WLDN $91.33
- NEO $12.00
- AVG Volume (30 Days)
- WLDN 481.6K
- NEO 3.1M
- Earning Date
- WLDN 08-07-2025
- NEO 07-29-2025
- Dividend Yield
- WLDN N/A
- NEO N/A
- EPS Growth
- WLDN 94.22
- NEO N/A
- EPS
- WLDN 2.39
- NEO N/A
- Revenue
- WLDN $628,172,000.00
- NEO $689,189,000.00
- Revenue This Year
- WLDN N/A
- NEO $13.83
- Revenue Next Year
- WLDN $9.94
- NEO $11.35
- P/E Ratio
- WLDN $47.19
- NEO N/A
- Revenue Growth
- WLDN 13.82
- NEO 9.70
- 52 Week Low
- WLDN $30.43
- NEO $4.72
- 52 Week High
- WLDN $121.00
- NEO $19.12
- Technical
- Relative Strength Index (RSI)
- WLDN 74.34
- NEO 50.53
- Support Level
- WLDN $85.74
- NEO $5.37
- Resistance Level
- WLDN $121.00
- NEO $6.34
- Average True Range (ATR)
- WLDN 6.39
- NEO 0.39
- MACD
- WLDN 2.35
- NEO 0.13
- Stochastic Oscillator
- WLDN 82.07
- NEO 91.98
About WLDN Willdan Group Inc.
Willdan Group Inc is a provider of professional technical and consulting services to utilities, private industry, and public agencies at all levels of government. It operates in the business segments of Energy and Engineering and Consulting. It generates the majority of its revenue from the Energy segment, which includes services such as audit and surveys, program design, master planning, benchmarking analysis, design engineering, construction management, performance contracting, installation, advances in software and data analytics, and other services. All of its revenue is derived from the domestic markets.
About NEO NeoGenomics Inc.
NeoGenomics Inc provides oncology diagnostic testing and consultative services which include technical laboratory services and professional interpretation of laboratory test results by licensed physicians or molecular experts in pathology and oncology. It operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company operates in a single segment and derives revenue from clients by providing clinical cancer testing, interpretation, and consultative services, molecular and NGS testing, comprehensive technical and professional services offerings, clinical trials and research, validation laboratory services, and oncology data solutions.